Published in J Endocrinol Invest on June 01, 2007
Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain (2012) 2.69
Ictal laughter associated with paroxysmal hypothalamopituitary dysfunction. Epilepsia (1997) 2.14
Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol (Oxf) (1995) 2.08
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology (1997) 1.85
Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes (2000) 1.58
Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care (2000) 1.56
Deleterious effect of dithizone-DMSO staining on insulin secretion in rat and human pancreatic islets. Pancreas (1994) 1.45
[Insulin secretion and insulin sensitivity in relation to glucose tolerance in a group of subjects at a high risk for type 2 diabetes mellitus]. Med Clin (Barc) (2001) 1.42
Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial). Int J Obes (Lond) (2010) 1.42
Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol (2001) 1.39
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS (1999) 1.34
Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes (1998) 1.23
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod (2001) 1.19
Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes. Diabetes Care (2000) 1.12
Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab (1983) 1.10
The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes (1997) 1.06
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod (2000) 1.06
Relationship between 25-(OH) D3, the IGF-I system, leptin, anthropometric and body composition variables in a healthy, randomly selected population. Horm Metab Res (2004) 1.02
Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res (2001) 1.01
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy. Clin Infect Dis (2000) 1.00
Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol (1996) 0.97
Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose. Diabet Med (2003) 0.93
Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid (1998) 0.92
Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery (1997) 0.91
Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes (1993) 0.91
Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Physiol (1990) 0.90
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients. J Assist Reprod Genet (1998) 0.89
Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. J Clin Endocrinol Metab (1999) 0.89
Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon. J Lab Clin Med (2001) 0.89
Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study. Diabetes (1989) 0.88
Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients. J Intern Med (2009) 0.88
Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes. Metabolism (2003) 0.88
Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot. Hum Reprod (1992) 0.88
High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab (2010) 0.88
Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol (1988) 0.88
Integrin expression in normal and out-of-phase endometria. Hum Reprod (1998) 0.88
Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. Hum Reprod (2000) 0.88
Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein. Diabetes (1993) 0.87
Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake. J Endocrinol Invest (2009) 0.86
IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). Autoimmunity (1999) 0.86
Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol. J Assist Reprod Genet (2000) 0.86
Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis. Am J Physiol (1984) 0.85
Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation (1998) 0.85
Hemodynamic effects of glucagon in portal hypertension. Hepatology (1990) 0.85
Suppression by insulin treatment of glucose-induced inhibition of insulin release in non-insulin-dependent diabetics. Diabetes Res Clin Pract (1989) 0.84
Leptin is involved in gender-related differences in insulin sensitivity. Clin Endocrinol (Oxf) (1998) 0.84
Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families. Eur J Endocrinol (2000) 0.84
Circulating immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis, irritable bowel syndrome, and duodenal ulcer. Scand J Gastroenterol (1987) 0.84
A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with Type II diabetes mellitus. Diabetologia (2001) 0.83
Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies. Diabetes Care (2000) 0.83
High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community. Diabetes Res Clin Pract (1998) 0.83
Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology (1991) 0.83
The fat-free mass compartment influences serum leptin in men. Eur J Endocrinol (2000) 0.83
Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy. Clin Endocrinol (Oxf) (1999) 0.83
High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas (2001) 0.83
Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans. Clin Endocrinol (Oxf) (1999) 0.82
Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia (1989) 0.82
Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes (1999) 0.82
Long-term remission and recurrence rate in a cohort of Cushing's disease: the need for long-term follow-up. Pituitary (2015) 0.82
Role of thyroid hormones on serum leptin levels. Eur J Endocrinol (1998) 0.82
Relationship between ghrelin and the metabolic syndrome in the elderly: a longitudinal population-based study. Clin Endocrinol (Oxf) (2008) 0.82
Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes. Diabetes Care (1997) 0.82
Role of melatonin in health and disease. Clin Endocrinol (Oxf) (1995) 0.81
Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med (2001) 0.81
Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: the Di@bet.es Study. Ann Nutr Metab (2013) 0.81
T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol (2002) 0.81
Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren. Diabetologia (1987) 0.81
Characterization of Ti-C-N coatings deposited on Ti6Al4V for biomedical applications. J Inorg Biochem (2012) 0.80
Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome. J Assist Reprod Genet (2000) 0.80
Glucose regulation of islet amyloid polypeptide gene expression in rat pancreatic islets. Am J Physiol (1997) 0.80
A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome. Reprod Biomed Online (2003) 0.80
Functional properties of isolated human pancreatic islets beneficial effects of culture and exposure to high glucose concentrations. Diabete Metab (1995) 0.80
Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab (1998) 0.80
Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone. Acta Obstet Gynecol Scand (2000) 0.79
Hyperglucagonemia and hyperkinetic circulation after portocaval shunt in the rat. Am J Physiol (1987) 0.79
Iodine intake in the adult population. Di@bet.es study. Clin Nutr (2012) 0.79
Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support. Gynecol Endocrinol (1995) 0.79
Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod (2000) 0.79
Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment. Hepatology (1994) 0.79
The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. J Assist Reprod Genet (2001) 0.79
Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) gene expression in human pancreatic islets. Regul Pept (1997) 0.79
Long-term effect of ghrelin on nutritional status and functional capacity in the elderly: a population-based cohort study. Clin Endocrinol (Oxf) (2009) 0.79
Human pancreatic islet function at the onset of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1993) 0.79
Sexual dimorphism in N-acetyltransferase activity, hydroxyindole-O-methyltransferase activity, and melatonin content in the Harderian gland of Syrian hamsters: changes following gonadectomy. Proc Soc Exp Biol Med (1988) 0.79
Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation. Hepatology (1994) 0.78
Plasma soluble tumor necrosis factor-alpha receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women. Eur J Endocrinol (2000) 0.78
The efficacy of octreotide LAR as firstline therapy for patients with newly diagnosed acromegaly is independent of tumor extension: predictive factors of tumor and biochemical response. Horm Metab Res (2009) 0.78
Pituitary-thyroid axis, thyroid volume and leptin in healthy adults. Horm Metab Res (2002) 0.78
Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies. Diabet Med (2005) 0.78
Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol. Acta Obstet Gynecol Scand (1999) 0.78
Circannual somatostatin gene and somatostatin receptor gene expression in the early post-natal rat pineal gland. Neuroendocrinology (1997) 0.78
Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial. Diabet Med (1999) 0.78
[Insulin treatment in diabetes mellitus type II: the usefulness of the breakfast test]. Med Clin (Barc) (1995) 0.78
Glucose impairment and ghrelin gene variants are associated to cognitive dysfunction. Aging Clin Exp Res (2014) 0.78
Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study. Eur J Clin Nutr (2013) 0.78